Domain-Specific Foundation Model Improves AI-Based Analysis of Neuropathology

📅 2025-11-30
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Current general-purpose pathological foundation models are predominantly trained on non-neural tissue data, limiting their capacity to effectively represent neurospecific structures (e.g., neurons, glial cells) and neuropathological hallmarks (e.g., amyloid plaques, neurofibrillary tangles), thereby impeding AI-driven analysis of neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. To address this gap, we introduce NeuroFM—the first domain-specific foundation model tailored for whole-slide images (WSIs) of human brain tissue. NeuroFM leverages a large-scale, real-world neurohistopathological WSI dataset and adopts a Vision Transformer architecture trained via contrastive learning–based self-supervision. Extensive experiments demonstrate that NeuroFM significantly outperforms generalist models on downstream tasks including mixed dementia classification, hippocampal segmentation, and cerebellar ataxia subtype identification. These results underscore the critical importance of domain specialization in enhancing the robustness and diagnostic accuracy of AI systems for neuropathology.

Technology Category

Application Category

📝 Abstract
Foundation models have transformed computational pathology by providing generalizable representations from large-scale histology datasets. However, existing models are predominantly trained on surgical pathology data, which is enriched for non-nervous tissue and overrepresents neoplastic, inflammatory, metabolic, and other non-neurological diseases. Neuropathology represents a markedly different domain of histopathology, characterized by unique cell types (neurons, glia, etc.), distinct cytoarchitecture, and disease-specific pathological features including neurofibrillary tangles, amyloid plaques, Lewy bodies, and pattern-specific neurodegeneration. This domain mismatch may limit the ability of general-purpose foundation models to capture the morphological patterns critical for interpreting neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and cerebellar ataxias. To address this gap, we developed NeuroFM, a foundation model trained specifically on whole-slide images of brain tissue spanning diverse neurodegenerative pathologies. NeuroFM demonstrates superior performance compared to general-purpose models across multiple neuropathology-specific downstream tasks, including mixed dementia disease classification, hippocampal region segmentation, and neurodegenerative ataxia identification encompassing cerebellar essential tremor and spinocerebellar ataxia subtypes. This work establishes that domain-specialized foundation models trained on brain tissue can better capture neuropathology-specific features than models trained on general surgical pathology datasets. By tailoring foundation models to the unique morphological landscape of neurodegenerative diseases, NeuroFM enables more accurate and reliable AI-based analysis for brain disease diagnosis and research, setting a precedent for domain-specific model development in specialized areas of digital pathology.
Problem

Research questions and friction points this paper is trying to address.

General foundation models trained on surgical pathology data poorly capture neuropathology-specific morphological patterns
Existing models lack representation of unique brain cell types and neurodegenerative disease features
Domain mismatch limits AI analysis accuracy for Alzheimer's, Parkinson's, and cerebellar ataxias diagnosis
Innovation

Methods, ideas, or system contributions that make the work stand out.

Domain-specific foundation model for neuropathology analysis
Trained on whole-slide brain tissue images
Outperforms general models in neurodegenerative disease tasks
🔎 Similar Papers
No similar papers found.
Ruchika Verma
Ruchika Verma
Computational Scientist, Icahn School of Medicine at Mount Sinai
Computational PathologyMedical Image AnalysisMachine LearningDeep Learning
S
Shrishtee Kandoi
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
R
Robina Afzal
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
S
Shengjia Chen
Windreich Department of AI and Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J
Jannes Jegminat
Windreich Department of AI and Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
M
Michael W. Karlovich
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
M
Melissa Umphlett
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
T
Timothy E. Richardson
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
K
Kevin Clare
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Q
Quazi Hossain
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J
Jorge Samanamud
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
P
Phyllis L. Faust
Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.
E
Elan D. Louis
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
A
Ann C. McKee
VA Boston Healthcare System, Boston, MA, USA.
T
Thor D. Stein
Department of Pathology and Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.
J
Jonathan D. Cherry
Boston University Chronic Traumatic Encephalopathy Center, Boston University Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.
J
Jesse Mez
Boston University Alzheimer’s Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
A
Anya C. McGoldrick
Department of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.
D
Dalilah D. Quintana Mora
Department of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.
M
Melissa J. Nirenberg
Department of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.
R
Ruth H. Walker
Department of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.
Y
Yolfrankcis Mendez
Department of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.
S
Susan Morgello
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Dennis W. Dickson
Dennis W. Dickson
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
M
Melissa E. Murray
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA.